Bafna Pharmaceuticals Independent Director Retires

Director Retirement Details

Mr. Navin Kumar (DIN: 08778662) retired as an Independent Director of the Company upon completion of his first term. The cessation took effect from close of business hours on June 22, 2026. Consequently, he ceased to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee of the Company.

Board Committee Reconstitution

Due to the change in board composition, the following committees were reconstituted with effect from June 23, 2026:

Audit Committee:

• Mr. Palamadai Krishnan Sundaresan - Chairman (Non-Executive, Independent)
• Mrs. Ravichandran Chitra - Member (Non-Executive, Independent)
• Mr. Upendar Mekala Reddy - Member (Non-Executive, Non-Independent)

Nomination and Remuneration Committee:

• Mr. Palamadai Krishnan Sundaresan - Chairman (Non-Executive, Independent)
• Mrs. Ravichandran Chitra - Member (Non-Executive, Independent)
• Mrs. Akila Chintalapati Raju - Member (Non-Executive, Non-Independent)

Compliance Status

The Company confirmed that notwithstanding the retirement of the Independent Director, the composition of the Board and its Committees continues to remain in compliance with the requirements of applicable laws.

Annexure Details

The annexure provided the following specific information:

• Name of Director: Mr. Navin Kumar
• DIN: 08778662
• Reason for change: Retirement upon completion of first term
• Date of Cessation: Close of Business Hours on June 22, 2026
• Brief Profile: Not Applicable
• Disclosure of relationships between directors: Nil